Leading science, pioneering therapies

CRM Publications

Found 5 results
Filters: Keyword is Multiple Sclerosis, Chronic Progressive  [Clear All Filters]
2012
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du M-Q, Luan S-L, Altmann DR, Thompson AJ et al..  2012.  Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.Lancet Neurol. 11(2):150-6.
2011
Connick P, Kolappan M, Patani R, Scott MA, Crawley C, He X-L, Richardson K, Barber K, Webber DJ, Wheeler-Kingshott CAM et al..  2011.  The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.Trials. 12:62.
2010
Anderson JMarian, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MGrazia, Chandran S.  2010.  Abnormal tau phosphorylation in primary progressive multiple sclerosis.Acta Neuropathol. 119(5):591-600.
2008
Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, ffrench-Constant C, Giovannoni G, Compston DAS, Baker D et al..  2008.  Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.Brain. 131(Pt 7):1736-48.
Hampton DW, Anderson J, Pryce G, Irvine K-A, Giovannoni G, Fawcett JW, Compston A, Franklin RJM, Baker D, Chandran S.  2008.  An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss.J Neuroimmunol. 201-202:200-11.